Biostatistics is the branch of statistics that applies mathematical and statistical methods to the design, analysis, and interpretation of data in the biological and health sciences. It provides the quantitative backbone for medical research, epidemiology, public health, genomics, and clinical trials. Without biostatistics, researchers would have no rigorous way to determine whether a new drug actually works, whether a risk factor truly causes disease, or whether a public health intervention is saving lives.
The field emerged in the late nineteenth and early twentieth centuries through the pioneering work of Francis Galton, Karl Pearson, and Ronald Fisher, who developed foundational techniques such as regression analysis, correlation, and the analysis of variance. These methods were originally created to study biological variation and heredity, and they remain central to modern biostatistics. Today the discipline has expanded to encompass survival analysis, longitudinal data modeling, Bayesian inference, and high-dimensional methods for genomics and proteomics data.
Biostatistics plays a critical role in evidence-based medicine and regulatory science. The design and analysis of randomized controlled trials, the gold standard for evaluating medical interventions, is fundamentally a biostatistical enterprise. Government agencies such as the FDA and EMA rely on biostatistical evidence to approve new therapies. In public health, biostatisticians model disease outbreaks, estimate vaccine effectiveness, and analyze health disparities across populations, making the field indispensable to modern healthcare and scientific discovery.